Tempest Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tempest Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Tempest Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $8.9M, a 14.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $8.9M -$1.48M -14.2% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $9.16M -$1.65M -15.2% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $9.51M -$1.71M -15.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $9.95M -$1.7M -14.6% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $10.4M +$9.07M +691% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $10.8M +$9.25M +596% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $11.2M +$8.48M +310% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $11.7M +$8.6M +282% Dec 31, 2022 10-K 2024-03-19
Q3 2022 $1.31M -$2.05M -60.9% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $1.55M -$2.12M -57.7% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $2.74M -$312K -10.2% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $3.05M +$1.17M +62.5% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $3.36M +$1.48M +78.8% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $3.67M +$1.06M +40.4% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $3.05M +$185K +6.46% Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $1.88M -$1.45M -43.7% Dec 31, 2020 10-K 2022-03-29
Q3 2020 $1.88M -$1.69M -47.4% Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $2.62M +$267K +11.4% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $2.87M +$2.07M +260% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $3.33M Dec 31, 2019 10-K 2021-03-29
Q3 2019 $3.57M Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $2.35M Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $797K Mar 31, 2019 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.